A Randomised trial of anti-GM-CSF Otilimab in severe COVID-19 pneumonia (OSCAR)
(Mark Tidswell)
All Scholarly Works
(2022)
Abstract BACKGROUND: Granulocyte-macrophage colony-stimulating factor (GM-CSF) and dysregulated myeloid cell responses are implicated in the pathophysiology and severity of coronavirus disease 2019 (COVID-19). Methods: In this randomised, sequential, multicentre, placebo-controlled, double-blind study, adults aged 18-79 ...